Issue Navigation
-
Review
-
123-128
Menaquinone as a potential target of antibacterial agents.
Paudel A, Hamamoto H, Panthee S, Sekimizu K
Drug Discov Ther. 2016; 10(3):123-128.
DOI: 10.5582/ddt.2016.01041
-
129-140
Reevaluation of antithrombotic fruits and vegetables: great variation between varieties.
Yamamoto J, Ijiri Y, Tamura Y, Iwasaki M, Murakami M, Okada Y
Drug Discov Ther. 2016; 10(3):129-140.
DOI: 10.5582/ddt.2016.01043
-
141-149
Mabou FD, Tamokou J-d-D, Ngnokam D, Voutquenne-Nazabadioko L, Kuiate JR, Bag PK
Drug Discov Ther. 2016; 10(3):141-149.
DOI: 10.5582/ddt.2016.01040
-
150-155
Development of chrysin loaded poloxamer micelles and toxicity evaluation in fish embryos.
Sassa-deepaeng T, Pikulkaew S, Okonogi S
Drug Discov Ther. 2016; 10(3):150-155.
DOI: 10.5582/ddt.2016.01039
-
156-162
Ito I, Ito A, Unezaki S
Drug Discov Ther. 2016; 10(3):156-162.
DOI: 10.5582/ddt.2016.01034
-
163-166
Discovery of N-hydroxy-4-(1H-indol-3-yl)butanamide as a histone deacetylase inhibitor.
Bian J, Luan YP, Wang CB, Zhang L
Drug Discov Ther. 2016; 10(3):163-166.
DOI: 10.5582/ddt.2016.01031
-
167-171
An ultra-low-molecular-weight heparin, fondaparinux, to treat retinal vein occlusion.
Steigerwalt Jr. RD, Pascarella A, De Angelis M, Ciucci F, Gaudenzi F
Drug Discov Ther. 2016; 10(3):167-171.
DOI: 10.5582/ddt.2016.01037
-
172-176
Cytokine expression profiles in the sera of cutaneous squamous cell carcinoma patients.
Yamada S, Jinnin M, Kajihara I, Nakashima T, Aoi J, Harada M, Igata T, Masuguchi S, Fukushima S, Ihn H
Drug Discov Ther. 2016; 10(3):172-176.
DOI: 10.5582/ddt.2016.01032
-
177-180
Steigerwalt Jr. RD, Pascarella A, De Angelis M, Grimaldi G, Nebbioso M
Drug Discov Ther. 2016; 10(3):177-180.
DOI: 10.5582/ddt.2016.01036